Related Experiment Video

Updated: May 25, 2025

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.1K

NFIX suppresses breast cancer cell proliferation by delaying mitosis through downregulation of CDK1 expression

Hai-Yan Ma1,2,3,4, Rui Sun1,2,3,4, Tian Tian1,2,3,4,5

  • 1The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.

Cell Death Discovery
|February 25, 2025
PubMed

Insights

Nuclear Factor I-B (NFIX) acts as a tumor suppressor in breast cancer by inhibiting cell proliferation. Upregulating NFIX delays cell cycle progression and impacts prognosis, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Uncontrolled cell growth is a hallmark of malignant tumors, contributing to breast cancer's incurability.
  • Nuclear Factor I-B (NFIX) is implicated in various cancers, but its specific role in breast cancer requires further investigation.

Purpose of the Study:

  • To investigate the expression of NFIX in breast cancer.
  • To elucidate the function of NFIX in inhibiting breast cancer cell cycle progression and proliferation.

Main Methods:

  • Comparative analysis of NFIX expression in breast cancer versus normal breast tissue.
  • In vitro and in vivo experiments to assess the effects of NFIX overexpression on cell cycle and proliferation.
  • Investigation of NFIX's molecular mechanisms involving CDK1, YBX1, and promoter methylation.

Main Results:

  • NFIX is downregulated in breast cancer, correlating with poorer prognosis.
  • Overexpression of NFIX induces a G2/M phase delay, inhibiting breast cancer cell proliferation.
  • NFIX enhances CDK1 degradation and represses its transcription, while its expression is linked to promoter methylation.

Conclusions:

  • NFIX functions as a tumor suppressor in breast cancer by inhibiting cell proliferation.
  • NFIX plays a critical role in regulating cell cycle transitions via CDK1.
  • NFIX expression and its regulatory mechanisms offer potential therapeutic avenues for breast cancer.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.2K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
2.9K